Maha Abdalla Mohamed, MD
Nephrology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 18
- 4 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
18 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mohamed’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
18 of 18 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A68748 · Current
Licensed to practise in California · since 2023 · expires 2027-05-31 · University of Khartoum Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$42,583
Medicare paid this office $42,583 for 197 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 90 | $9,844 | $43 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $4,232 | $71 |
| Short return visit (20+ min) | 30 | $4,032 | $52 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 43 | $3,628 | $73 |
| Long return visit (40+ min) | 21 | $3,127 | $125 |
See all 9 services
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 90 | $9,844 | $43 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $4,232 | $71 |
| Short return visit (20+ min) | 30 | $4,032 | $52 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 43 | $3,628 | $73 |
| Long return visit (40+ min) | 21 | $3,127 | $125 |
| Return visit (30+ min) | 17 | $2,326 | $83 |
| New patient visit (60+ min) | 14 | $2,115 | $151 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $1,967 | $116 |
| Hemodialysis procedure with physician evaluation | 15 | $1,324 | $63 |
Who their Medicare patients are
197 Original Medicare patients in 2024. Average age 60 · Under 65 53% · Women 47% · Also on Medicaid 64% · Health risk score 7.21. Sicker patients than 9 in 10 peers; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 60% · Coronary heart disease 46% · Heart failure 45% · Atrial fibrillation 27% · Depression 26% · Dementia 16% · Cancer 15% · COPD 15% · Stroke 15%.
The office billed $213,689, Medicare allowed $55,254 and paid $42,583; for 635 services of 20 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 197 | 635 | 60 | 7.21 | $213,689 | $42,583 |
| 2023 | 229 | 616 | 63 | 5.39 | $193,324 | $35,045 |
| 2022 | 331 | 1,393 | 61 | 3.69 | $357,738 | $50,544 |
| 2021 | 287 | 1,224 | 60 | 3.31 | $255,914 | $39,115 |
| 2020 | 356 | 1,553 | 60 | 4.16 | $300,972 | $48,741 |
| 2019 | 407 | 2,110 | 60 | 4.34 | $446,007 | $76,628 |
| 2018 | 424 | 1,956 | 58 | 3.69 | $344,568 | $60,390 |
| 2017 | 476 | 2,158 | 58 | 3.91 | $414,801 | $74,918 |
| 2016 | 488 | 2,625 | 57 | 3.91 | $461,156 | $84,501 |
| 2015 | 447 | 1,816 | 58 | 4.27 | $377,181 | $70,284 |
| 2014 | 403 | 1,578 | 56 | 3.83 | $406,889 | $78,712 |
| 2013 | 481 | 1,909 | 56 | 4.33 | $542,147 | $100,978 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Return visit (30+ min) | 89 | $6,440 | $69 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 43 | $4,722 | $44 |
| Long return visit (40+ min) | 26 | $3,647 | $118 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $3,560 | $89 |
| Short return visit (20+ min) | 16 | $2,802 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $2,287 | $64 |
| Needle biopsy of kidney | 21 | $1,980 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,686 | $130 |
| Hemodialysis procedure with physician evaluation | 16 | $1,506 | $60 |
| Return visit (30+ min) | 13 | $1,215 | $93 |
| Hospital discharge day management, 30 minutes or less | 11 | $739 | $62 |
| Short return visit (20+ min) | 13 | $668 | $48 |
| Insertion of needle into vein for collection of blood sample | 13 | $328 | $8 |
| Ultrasonic guidance for needle placement | 14 | $162 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 11 | $90 | $8 |
2022: 18 services
| Return visit (30+ min) | 154 | $13,190 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $10,611 | $76 |
| Needle biopsy of kidney | 46 | $5,250 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $4,277 | $52 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 23 | $1,712 | $74 |
| Short return visit (20+ min) | 24 | $1,612 | $67 |
| Return visit (30+ min) | 15 | $1,429 | $89 |
| Hospital discharge day management, 30 minutes or less | 24 | $1,352 | $52 |
| Short return visit (20+ min) | 16 | $1,012 | $48 |
| Hemodialysis procedure with physician evaluation | 12 | $880 | $55 |
| Ultrasonic guidance for needle placement | 45 | $753 | $13 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $345 | $23 |
| Blood creatinine level | 15 | $339 | $5 |
| Blood potassium level | 15 | $312 | $5 |
| Insertion of needle into vein for collection of blood sample | 24 | $285 | $3 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 19 | $211 | $9 |
| Automated white blood cell count | 14 | $179 | $2 |
| Red blood cell concentration measurement | 14 | $167 | $2 |
2021: 24 services
| Return visit (30+ min) | 162 | $14,650 | $72 |
| Needle biopsy of kidney | 40 | $4,467 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $3,499 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $3,237 | $75 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 21 | $1,742 | $76 |
| Hospital discharge day management, 30 minutes or less | 26 | $1,511 | $54 |
| Short return visit (20+ min) | 28 | $1,393 | $48 |
| Long return visit (40+ min) | 11 | $1,347 | $112 |
| Telephone medical discussion with physician, 11-20 minutes | 19 | $909 | $48 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $764 | $69 |
| Ultrasonic guidance for needle placement | 40 | $576 | $13 |
| Insertion of needle into vein for collection of blood sample | 20 | $273 | $3 |
| Blood creatinine level | 16 | $269 | $5 |
| Blood potassium level | 14 | $246 | $4 |
| Automated white blood cell count | 15 | $144 | $2 |
| Red blood cell concentration measurement | 15 | $132 | $2 |
| Glutamyltransferase (liver enzyme) level | 11 | $74 | $7 |
| Creatinine level to test for kidney function or muscle injury | 12 | $65 | $5 |
| Liver enzyme (sgpt), level | 11 | $54 | $5 |
| Phosphatase (enzyme) level, alkaline | 11 | $53 | $5 |
| Liver enzyme (sgot), level | 11 | $53 | $5 |
| Manual urinalysis test with examination using microscope, automated | 12 | $52 | $3 |
| Bilirubin level, total | 11 | $52 | $5 |
| Total protein level, urine | 12 | $46 | $3 |
2020: 25 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 48 | $8,729 | $81 |
| Return visit (30+ min) | 102 | $7,142 | $59 |
| Needle biopsy of kidney | 44 | $4,906 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 46 | $4,399 | $55 |
| Telephone medical discussion with physician, 21-30 minutes | 38 | $2,502 | $60 |
| Hemodialysis procedure with physician evaluation | 20 | $2,058 | $57 |
| Hospital discharge day management, 30 minutes or less | 34 | $1,890 | $56 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 24 | $1,870 | $78 |
| Telephone medical discussion with physician, 11-20 minutes | 41 | $1,690 | $38 |
| Long return visit (40+ min) | 17 | $1,545 | $86 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | $1,280 | $85 |
| Short return visit (20+ min) | 28 | $1,148 | $40 |
| Return visit (30+ min) | 11 | $899 | $82 |
| Telephone medical discussion with physician, 11-20 minutes | 15 | $821 | $55 |
| Ultrasonic guidance for needle placement | 43 | $671 | $14 |
| Blood creatinine level | 17 | $410 | $5 |
| Blood potassium level | 16 | $371 | $5 |
| Insertion of needle into vein for collection of blood sample | 25 | $337 | $3 |
| Automated white blood cell count | 16 | $198 | $2 |
| Red blood cell concentration measurement | 16 | $185 | $2 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 13 | $108 | $8 |
| Magnesium level | 11 | $87 | $7 |
| Creatinine level to test for kidney function or muscle injury | 12 | $84 | $5 |
| Manual urinalysis test with examination using microscope, automated | 12 | $63 | $3 |
| Total protein level, urine | 12 | $60 | $4 |
2019: 18 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 75 | $17,518 | $81 |
| Return visit (30+ min) | 176 | $12,772 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 78 | $8,014 | $56 |
| Needle biopsy of kidney | 70 | $7,830 | $99 |
| Long return visit (40+ min) | 55 | $5,313 | $82 |
| Return visit (30+ min) | 48 | $4,200 | $84 |
| Hospital discharge day management, 30 minutes or less | 57 | $3,405 | $57 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 30 | $2,335 | $78 |
| Hemodialysis procedure with physician evaluation | 24 | $2,005 | $56 |
| Long return visit (40+ min) | 20 | $1,989 | $99 |
| Ultrasonic guidance for needle placement | 65 | $971 | $13 |
| Short return visit (20+ min) | 18 | $714 | $40 |
| Blood creatinine level | 22 | $698 | $6 |
| Blood potassium level | 22 | $631 | $5 |
| Insertion of needle into vein for collection of blood sample | 25 | $491 | $3 |
| Blood glucose (sugar) level | 15 | $342 | $4 |
| Automated white blood cell count | 21 | $342 | $3 |
| Red blood cell concentration measurement | 21 | $320 | $3 |
2018: 25 services
| Return visit (30+ min) | 180 | $11,505 | $53 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 63 | $10,437 | $78 |
| Long return visit (40+ min) | 74 | $6,411 | $77 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 65 | $6,407 | $55 |
| Needle biopsy of kidney | 49 | $5,274 | $100 |
| Return visit (30+ min) | 42 | $3,316 | $77 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 26 | $2,068 | $77 |
| Hospital discharge day management, 30 minutes or less | 32 | $1,851 | $54 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,702 | $155 |
| Hemodialysis procedure with physician evaluation | 18 | $1,397 | $56 |
| Blood creatinine level | 20 | $813 | $6 |
| Blood potassium level | 19 | $702 | $5 |
| Ultrasonic guidance for needle placement | 47 | $665 | $13 |
| Short return visit (20+ min) | 14 | $548 | $39 |
| Parathormone (parathyroid hormone) level | 11 | $528 | $48 |
| Insertion of needle into vein for collection of blood sample | 26 | $429 | $3 |
| Automated white blood cell count | 19 | $406 | $3 |
| Red blood cell concentration measurement | 20 | $385 | $3 |
| Blood glucose (sugar) level | 14 | $361 | $5 |
| Urea nitrogen level to assess kidney function, quantitative | 12 | $239 | $5 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 12 | $122 | $9 |
| Creatinine level to test for kidney function or muscle injury | 17 | $116 | $6 |
| Glutamyltransferase (liver enzyme) level | 11 | $109 | $8 |
| Total protein level, urine | 16 | $78 | $4 |
| Manual urinalysis test with examination using microscope, automated | 18 | $77 | $4 |
2017: 29 services
| Return visit (30+ min) | 194 | $14,335 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 74 | $12,499 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 82 | $7,686 | $54 |
| Needle biopsy of kidney | 55 | $6,322 | $97 |
| Return visit (30+ min) | 66 | $5,443 | $79 |
| Long return visit (40+ min) | 56 | $4,980 | $80 |
| Hospital discharge day management, 30 minutes or less | 60 | $3,726 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,252 | $155 |
| Hemodialysis procedure with physician evaluation | 31 | $2,446 | $56 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 30 | $2,307 | $77 |
| Long return visit (40+ min) | 12 | $1,336 | $111 |
| Ultrasonic guidance for needle placement | 52 | $806 | $13 |
| Short return visit (20+ min) | 13 | $475 | $37 |
| Blood creatinine level | 20 | $414 | $3 |
| Insertion of needle into vein for collection of blood sample | 24 | $409 | $3 |
| Automated white blood cell count | 19 | $392 | $3 |
| Red blood cell concentration measurement | 20 | $372 | $3 |
| Blood potassium level | 19 | $312 | $3 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 12 | $219 | $10 |
| Blood glucose (sugar) level | 17 | $201 | $2 |
| Creatinine level to test for kidney function or muscle injury | 13 | $188 | $7 |
| Urea nitrogen level to assess kidney function, quantitative | 11 | $134 | $2 |
| Total protein level, urine | 13 | $133 | $5 |
| Manual urinalysis test with examination using microscope, automated | 18 | $119 | $4 |
| Glutamyltransferase (liver enzyme) level | 11 | $28 | $2 |
| Liver enzyme (sgpt), level | 11 | $24 | $2 |
| Phosphatase (enzyme) level, alkaline | 11 | $22 | $2 |
| Liver enzyme (sgot), level | 11 | $19 | $2 |
| Bilirubin level, total | 11 | $19 | $2 |
2016: 25 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 82 | $16,815 | $79 |
| Return visit (30+ min) | 210 | $15,878 | $57 |
| Needle biopsy of kidney | 74 | $8,715 | $108 |
| Long return visit (40+ min) | 74 | $6,626 | $76 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 65 | $6,070 | $55 |
| Return visit (30+ min) | 66 | $5,618 | $78 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $3,630 | $151 |
| Hospital discharge day management, 30 minutes or less | 56 | $3,463 | $55 |
| Hemodialysis procedure with physician evaluation | 32 | $2,629 | $56 |
| New patient visit (30+ min) | 27 | $1,400 | $52 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 16 | $1,232 | $77 |
| Long return visit (40+ min) | 14 | $1,214 | $87 |
| Short return visit (20+ min) | 29 | $1,104 | $37 |
| Insertion of needle into vein for collection of blood sample | 27 | $532 | $3 |
| Automated white blood cell count | 21 | $529 | $3 |
| Ultrasonic guidance for needle placement | 35 | $505 | $14 |
| Red blood cell concentration measurement | 23 | $501 | $3 |
| Blood creatinine level | 24 | $464 | $3 |
| Blood potassium level | 22 | $346 | $2 |
| Blood glucose (sugar) level | 22 | $272 | $2 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 11 | $270 | $10 |
| Urea nitrogen level to assess kidney function, quantitative | 22 | $264 | $2 |
| Creatinine level to test for kidney function or muscle injury | 15 | $117 | $7 |
| Manual urinalysis test with examination using microscope, automated | 13 | $110 | $4 |
| Total protein level, urine | 15 | $83 | $5 |
2015: 23 services
| Long return visit (40+ min) | 137 | $12,947 | $80 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 67 | $10,474 | $79 |
| Return visit (30+ min) | 121 | $7,402 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 70 | $7,222 | $55 |
| Hemodialysis procedure with physician evaluation | 41 | $5,427 | $56 |
| Needle biopsy of kidney | 47 | $5,005 | $104 |
| Long return visit (40+ min) | 41 | $4,212 | $98 |
| Hospital discharge day management, 30 minutes or less | 52 | $3,229 | $54 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,333 | $156 |
| Return visit (30+ min) | 29 | $2,303 | $77 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 23 | $1,855 | $77 |
| New patient visit (30+ min) | 15 | $876 | $58 |
| Ultrasonic guidance for needle placement | 47 | $654 | $14 |
| Short return visit (20+ min) | 14 | $503 | $36 |
| Insertion of needle into vein for collection of blood sample | 20 | $303 | $3 |
| Automated white blood cell count | 17 | $297 | $3 |
| Red blood cell concentration measurement | 18 | $281 | $3 |
| Blood creatinine level | 20 | $263 | $3 |
| Urea nitrogen level to assess kidney function, quantitative | 20 | $217 | $2 |
| Blood potassium level | 17 | $185 | $2 |
| Blood glucose (sugar) level | 19 | $153 | $2 |
| Creatinine level to test for kidney function or muscle injury | 12 | $124 | $7 |
| Total protein level, urine | 11 | $83 | $5 |
2014: 16 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 89 | $13,922 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 98 | $11,499 | $55 |
| Needle biopsy of kidney | 63 | $7,599 | $110 |
| Return visit (30+ min) | 122 | $7,554 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $6,345 | $155 |
| Hemodialysis procedure with physician evaluation | 46 | $6,328 | $56 |
| Long return visit (40+ min) | 75 | $6,272 | $76 |
| Hospital discharge day management, 30 minutes or less | 67 | $4,333 | $55 |
| Return visit (30+ min) | 40 | $3,175 | $76 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 21 | $1,590 | $76 |
| Long return visit (40+ min) | 16 | $1,561 | $98 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,258 | $105 |
| Ultrasonic guidance for needle placement | 60 | $920 | $14 |
| Short return visit (20+ min) | 15 | $541 | $36 |
| Insertion of needle into vein for collection of blood sample | 15 | $165 | $3 |
| Red blood cell concentration measurement | 11 | $160 | $3 |
2013: 20 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 108 | $18,624 | $77 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 133 | $14,919 | $53 |
| Long return visit (40+ min) | 133 | $11,440 | $73 |
| Hemodialysis procedure with physician evaluation | 84 | $10,728 | $54 |
| Needle biopsy of kidney | 80 | $9,521 | $106 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 50 | $8,289 | $148 |
| Hospital discharge day management, 30 minutes or less | 66 | $4,046 | $53 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 36 | $3,825 | $101 |
| Return visit (30+ min) | 66 | $3,718 | $55 |
| Long return visit (40+ min) | 37 | $3,717 | $86 |
| Hospital discharge day management, more than 30 minutes | 18 | $1,627 | $77 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 20 | $1,578 | $75 |
| Ultrasonic guidance for needle placement | 75 | $1,390 | $17 |
| Return visit (30+ min) | 14 | $1,067 | $76 |
| Insertion of needle into vein for collection of blood sample | 15 | $177 | $3 |
| Blood creatinine level | 11 | $144 | $3 |
| Creatinine level to test for kidney function or muscle injury | 12 | $133 | $7 |
| Urea nitrogen level to assess kidney function, quantitative | 11 | $123 | $3 |
| Total protein level, urine | 12 | $89 | $5 |
| Blood glucose (sugar) level | 11 | $62 | $1 |
Medicaid work
$3,283 in 2024
Medicaid paid $3,283 for 189 billed services this clinician did in 2024, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 128 | $1,391 |
| IP/OBS CONSLTJ NEW/EST SF 35 | 33 | $1,347 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 28 | $545 |
| 2024 | 189 | 3 | 22 | $3,283 |
| 2023 | 71 | 1 | 24 | $1,282 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 71 | $1,282 |
Drugs they prescribed that Part D paid
$116,932
Pharmacies billed $116,932 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 630) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
546 generic and fewer than 11 brand-name prescriptions · $116,932 in drug cost · 39 antibiotic prescriptions to 17 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Atovaquone | 52 | $19,106 | $367 |
| Trulicity | 17 | $15,167 | $892 |
| Entecavir | 12 | $6,078 | $507 |
| Basaglar Kwikpen U-100 | 15 | $4,609 | $307 |
| Cinacalcet | 29 | $4,448 | $153 |
See all 19 drugs
| Atovaquone | 52 | $19,106 | $367 |
| Trulicity | 17 | $15,167 | $892 |
| Entecavir | 12 | $6,078 | $507 |
| Basaglar Kwikpen U-100 | 15 | $4,609 | $307 |
| Cinacalcet | 29 | $4,448 | $153 |
| Valganciclovir | 11 | $2,607 | $237 |
| Tacrolimus | 16 | $624 | $39 |
| Nifedipine Er | 20 | $558 | $28 |
| Potassium Chloride | 11 | $530 | $48 |
| Carvedilol | 68 | $488 | $7 |
| Pantoprazole | 38 | $446 | $12 |
| Ursodiol | 12 | $384 | $32 |
| Prednisone | 49 | $311 | $6 |
| Amlodipine Besylate | 40 | $272 | $7 |
| Sulfamethoxazole-Trimethoprim | 21 | $225 | $11 |
| Atorvastatin | 31 | $197 | $6 |
| Famotidine | 24 | $111 | $5 |
| Metoprolol | 17 | $74 | $4 |
| Furosemide | 12 | $46 | $4 |
Year by year
| 2024 | 630 | 100 | 0% (0) | None | $116,932 |
| 2023 | 1,880 | 235 | 0% (0) | 3% | $113,299 |
| 2022 | 2,672 | 248 | 0% (0) | None | $198,752 |
| 2021 | 2,727 | 247 | 0% (0) | None | $227,478 |
| 2020 | 3,177 | 266 | 0% (0) | None | $295,721 |
| 2019 | 3,561 | 301 | None | None | $255,712 |
| 2018 | 3,957 | 325 | 0% (0) | None | $315,189 |
| 2017 | 4,945 | 385 | None | 9% | $422,160 |
| 2016 | 5,193 | 385 | None | None | $343,675 |
| 2015 | 3,892 | 340 | 0% (16) | 8% | $222,741 |
| 2014 | 3,612 | 270 | 1% (19) | 11% | $250,177 |
| 2013 | 2,579 | 216 | 0% (11) | 12% | $201,309 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 29 drugs
| Cinacalcet | 34 | $19,321 | $568 |
| Mycophenolic Acid | 25 | $7,016 | $281 |
| Tacrolimus | 42 | $5,605 | $133 |
| Nifedipine Er | 112 | $4,592 | $41 |
| Potassium Chloride | 35 | $3,644 | $104 |
| Carvedilol | 135 | $2,758 | $20 |
| Prednisone | 333 | $2,647 | $8 |
| Pantoprazole | 127 | $2,235 | $18 |
| Mycophenolate Mofetil | 14 | $1,476 | $105 |
| Omeprazole | 35 | $1,250 | $36 |
| Losartan | 86 | $1,173 | $14 |
| Atorvastatin | 78 | $1,133 | $15 |
| Calcitriol | 64 | $1,126 | $18 |
| Hydralazine | 42 | $909 | $22 |
| Lisinopril | 73 | $892 | $12 |
| Metoprolol | 36 | $881 | $24 |
| Sulfamethoxazole-Trimethoprim | 48 | $790 | $16 |
| Amlodipine Besylate | 84 | $754 | $9 |
| Bumetanide | 11 | $697 | $63 |
| Furosemide | 75 | $678 | $9 |
| Allopurinol | 20 | $659 | $33 |
| Metoprolol | 52 | $489 | $9 |
| Chlorthalidone | 22 | $485 | $22 |
| Simvastatin | 25 | $248 | $10 |
| Alendronate | 20 | $247 | $12 |
| Tamsulosin | 14 | $236 | $17 |
| Famotidine | 17 | $202 | $12 |
| Azithromycin | 12 | $146 | $12 |
| Vitamin D2 | 30 | $77 | $3 |
2022: 33 drugs
| Mycophenolic Acid | 50 | $35,119 | $702 |
| Aranesp | 13 | $34,323 | $2,640 |
| Cinacalcet | 55 | $20,905 | $380 |
| Tacrolimus | 89 | $12,973 | $146 |
| Nifedipine Er | 167 | $6,805 | $41 |
| Potassium Chloride | 77 | $5,362 | $70 |
| Prednisone | 455 | $3,890 | $9 |
| Carvedilol | 199 | $3,216 | $16 |
| Cyclosporine Modified | 18 | $2,775 | $154 |
| Pantoprazole | 167 | $2,535 | $15 |
| Mycophenolate Mofetil | 13 | $2,210 | $170 |
| Losartan | 125 | $1,711 | $14 |
| Metoprolol | 47 | $1,665 | $35 |
| Omeprazole | 64 | $1,458 | $23 |
| Hydralazine | 39 | $1,182 | $30 |
| Calcitriol | 78 | $1,013 | $13 |
| Atorvastatin | 99 | $1,009 | $10 |
| Amlodipine Besylate | 108 | $984 | $9 |
| Furosemide | 109 | $888 | $8 |
| Lisinopril | 81 | $758 | $9 |
| Tamsulosin | 43 | $738 | $17 |
| Metoprolol | 76 | $557 | $7 |
| Sulfamethoxazole-Trimethoprim | 61 | $556 | $9 |
| Chlorthalidone | 34 | $533 | $16 |
| Allopurinol | 27 | $533 | $20 |
| Minoxidil | 15 | $522 | $35 |
| Alendronate | 25 | $442 | $18 |
| Nitrofurantoin Mono-Macro | 16 | $288 | $18 |
| Nystatin | 11 | $278 | $25 |
| Simvastatin | 29 | $265 | $9 |
| Propranolol | 16 | $221 | $14 |
| Vitamin D2 | 23 | $90 | $4 |
| Azithromycin | 13 | $76 | $6 |
2021: 38 drugs
| Mycophenolic Acid | 58 | $49,707 | $857 |
| Cinacalcet | 84 | $37,102 | $442 |
| Tacrolimus | 83 | $13,930 | $168 |
| Valganciclovir | 23 | $10,409 | $453 |
| Nifedipine Er | 195 | $10,397 | $53 |
| Potassium Chloride | 57 | $3,888 | $68 |
| Prednisone | 364 | $3,490 | $10 |
| Carvedilol | 241 | $3,258 | $14 |
| Leflunomide | 34 | $2,488 | $73 |
| Pantoprazole | 152 | $2,330 | $15 |
| Cyclosporine Modified | 33 | $2,225 | $67 |
| Valacyclovir | 13 | $1,934 | $149 |
| Calcitriol | 79 | $1,744 | $22 |
| Omeprazole | 79 | $1,672 | $21 |
| Losartan | 104 | $1,450 | $14 |
| Mycophenolate Mofetil | 11 | $1,344 | $122 |
| Hydralazine | 52 | $1,334 | $26 |
| Metoprolol | 37 | $1,115 | $30 |
| Amlodipine Besylate | 116 | $1,051 | $9 |
| Chlorthalidone | 50 | $987 | $20 |
| Furosemide | 121 | $871 | $7 |
| Lisinopril | 80 | $829 | $10 |
| Tamsulosin | 49 | $824 | $17 |
| Atorvastatin | 89 | $759 | $9 |
| Sulfamethoxazole-Trimethoprim | 53 | $611 | $12 |
| Metoprolol | 84 | $577 | $7 |
| Minoxidil | 16 | $522 | $33 |
| Alendronate | 33 | $505 | $15 |
| Allopurinol | 25 | $305 | $12 |
| Nitrofurantoin Mono-Macro | 14 | $182 | $13 |
| Acyclovir | 13 | $181 | $14 |
| Enalapril Maleate | 12 | $165 | $14 |
| Azithromycin | 12 | $131 | $11 |
| Torsemide | 14 | $124 | $9 |
| Simvastatin | 23 | $113 | $5 |
| Pravastatin | 14 | $100 | $7 |
| Clonidine | 15 | $86 | $6 |
| Vitamin D2 | 16 | $46 | $3 |
2020: 41 drugs
| Cinacalcet | 122 | $101,563 | $832 |
| Mycophenolic Acid | 70 | $64,935 | $928 |
| Tacrolimus | 95 | $25,063 | $264 |
| Nifedipine Er | 269 | $10,708 | $40 |
| Valganciclovir | 13 | $9,051 | $696 |
| Myfortic | 12 | $8,510 | $709 |
| Leflunomide | 55 | $5,461 | $99 |
| Ursodiol | 12 | $4,190 | $349 |
| Mycophenolate Mofetil | 28 | $4,141 | $148 |
| Prednisone | 481 | $3,899 | $8 |
| Carvedilol | 266 | $3,214 | $12 |
| Potassium Chloride | 50 | $3,012 | $60 |
| Hydralazine | 60 | $2,025 | $34 |
| Pantoprazole | 164 | $2,007 | $12 |
| Entecavir | 23 | $1,949 | $85 |
| Losartan | 111 | $1,705 | $15 |
| Calcitriol | 84 | $1,642 | $20 |
| Cyclosporine Modified | 17 | $1,483 | $87 |
| Metoprolol | 149 | $1,375 | $9 |
| Valacyclovir | 12 | $1,278 | $107 |
| Omeprazole | 72 | $1,234 | $17 |
| Furosemide | 160 | $866 | $5 |
| Atorvastatin | 75 | $848 | $11 |
| Lisinopril | 111 | $847 | $8 |
| Chlorthalidone | 27 | $786 | $29 |
| Amlodipine Besylate | 106 | $729 | $7 |
| Metoprolol | 24 | $677 | $28 |
| Tamsulosin | 56 | $667 | $12 |
| Alendronate | 33 | $538 | $16 |
| Minoxidil | 15 | $459 | $31 |
| Allopurinol | 35 | $427 | $12 |
| Sulfamethoxazole-Trimethoprim | 39 | $338 | $9 |
| Nitrofurantoin Mono-Macro | 14 | $300 | $21 |
| Ciprofloxacin | 14 | $277 | $20 |
| Pravastatin | 22 | $238 | $11 |
| Enalapril Maleate | 16 | $232 | $15 |
| Gemfibrozil | 13 | $153 | $12 |
| Triamcinolone Acetonide | 13 | $125 | $10 |
| Acyclovir | 13 | $107 | $8 |
| Simvastatin | 13 | $97 | $7 |
| Spironolactone | 11 | $95 | $9 |
2019: 44 drugs
| Sensipar | 43 | $48,313 | $1,124 |
| Cinacalcet | 51 | $38,467 | $754 |
| Mycophenolic Acid | 41 | $32,715 | $798 |
| Valganciclovir | 18 | $20,605 | $1,145 |
| Tacrolimus | 91 | $13,431 | $148 |
| Nifedipine Er | 276 | $10,540 | $38 |
| Entecavir | 11 | $10,275 | $934 |
| Leflunomide | 45 | $9,830 | $218 |
| Ursodiol | 19 | $6,186 | $326 |
| Prednisone | 571 | $4,481 | $8 |
| Carvedilol | 266 | $3,203 | $12 |
| Pantoprazole | 219 | $2,446 | $11 |
| Hydralazine | 83 | $2,403 | $29 |
| Calcitriol | 116 | $1,844 | $16 |
| Labetalol | 23 | $1,798 | $78 |
| Metoprolol | 52 | $1,637 | $31 |
| Potassium Chloride | 32 | $1,632 | $51 |
| Omeprazole | 108 | $1,511 | $14 |
| Metoprolol | 181 | $1,342 | $7 |
| Losartan | 96 | $1,338 | $14 |
| Mycophenolate Mofetil | 27 | $1,272 | $47 |
| Atorvastatin | 75 | $1,213 | $16 |
| Furosemide | 191 | $1,120 | $6 |
| Azathioprine | 12 | $991 | $83 |
| Lisinopril | 132 | $905 | $7 |
| Amlodipine Besylate | 118 | $780 | $7 |
| Minoxidil | 30 | $666 | $22 |
| Alendronate | 43 | $546 | $13 |
| Valacyclovir | 14 | $470 | $34 |
| Tamsulosin | 53 | $469 | $9 |
| Sulfamethoxazole-Trimethoprim | 47 | $400 | $9 |
| Allopurinol | 27 | $382 | $14 |
| Nystatin | 14 | $348 | $25 |
| Enalapril Maleate | 13 | $348 | $27 |
| Simvastatin | 38 | $316 | $8 |
| Ciprofloxacin | 18 | $312 | $17 |
| Clonidine | 22 | $238 | $11 |
| Pravastatin | 16 | $236 | $15 |
| Spironolactone | 21 | $231 | $11 |
| Gemfibrozil | 21 | $198 | $9 |
| Atenolol | 16 | $175 | $11 |
| Ranitidine | 18 | $148 | $8 |
| Acyclovir | 14 | $96 | $7 |
| Triamcinolone Acetonide | 12 | $28 | $2 |
2018: 42 drugs
| Valganciclovir | 40 | $88,875 | $2,222 |
| Sensipar | 44 | $54,022 | $1,228 |
| Mycophenolic Acid | 42 | $29,809 | $710 |
| Entecavir | 23 | $17,150 | $746 |
| Nifedipine Er | 278 | $11,088 | $40 |
| Leflunomide | 53 | $10,982 | $207 |
| Ursodiol | 24 | $8,377 | $349 |
| Tacrolimus | 59 | $7,399 | $125 |
| Prednisone | 565 | $4,189 | $7 |
| Calcitriol | 163 | $3,471 | $21 |
| Pantoprazole | 255 | $2,510 | $10 |
| Carvedilol | 260 | $2,447 | $9 |
| Metoprolol | 86 | $2,157 | $25 |
| Mycophenolate Mofetil | 25 | $1,853 | $74 |
| Hydralazine | 60 | $1,636 | $27 |
| Labetalol | 28 | $1,626 | $58 |
| Metoprolol | 216 | $1,523 | $7 |
| Atorvastatin | 98 | $1,455 | $15 |
| Omeprazole | 121 | $1,285 | $11 |
| Losartan | 107 | $1,269 | $12 |
| Furosemide | 190 | $1,189 | $6 |
| Lisinopril | 164 | $1,139 | $7 |
| Amlodipine Besylate | 163 | $979 | $6 |
| Tamsulosin | 56 | $927 | $17 |
| Doxazosin Mesylate | 20 | $773 | $39 |
| Enalapril Maleate | 18 | $723 | $40 |
| Minoxidil | 27 | $697 | $26 |
| Fenofibrate | 12 | $682 | $57 |
| Potassium Chloride | 21 | $622 | $30 |
| Sulfamethoxazole-Trimethoprim | 88 | $592 | $7 |
| Allopurinol | 40 | $570 | $14 |
| Alendronate | 82 | $452 | $6 |
| Simvastatin | 71 | $396 | $6 |
| Nystatin | 12 | $368 | $31 |
| Gemfibrozil | 32 | $281 | $9 |
| Ranitidine | 33 | $262 | $8 |
| Clonidine | 28 | $208 | $7 |
| Pravastatin | 13 | $148 | $11 |
| Acyclovir | 15 | $144 | $10 |
| Ciprofloxacin | 12 | $127 | $11 |
| Atenolol | 16 | $74 | $5 |
| Gabapentin | 18 | $62 | $3 |
2017: 58 drugs
| Valganciclovir | 47 | $117,053 | $2,490 |
| Sensipar | 48 | $61,131 | $1,274 |
| Mycophenolic Acid | 52 | $42,812 | $823 |
| Entecavir | 20 | $14,428 | $721 |
| Leflunomide | 51 | $13,035 | $256 |
| Nifedipine Er | 369 | $11,243 | $30 |
| Aranesp | 12 | $10,397 | $866 |
| Tacrolimus | 81 | $8,319 | $103 |
| Nexium | 15 | $7,642 | $509 |
| Ursodiol | 24 | $6,780 | $282 |
| Lantus Solostar | 14 | $6,010 | $429 |
| Prednisone | 601 | $4,537 | $8 |
| Vytorin | 14 | $4,390 | $314 |
| Metoprolol | 128 | $3,689 | $29 |
| Mycophenolate Mofetil | 40 | $3,510 | $88 |
| Labetalol | 55 | $3,434 | $62 |
| Cyclosporine Modified | 13 | $3,018 | $232 |
| Calcitriol | 141 | $2,936 | $21 |
| Pantoprazole | 298 | $2,733 | $9 |
| Potassium Chloride | 54 | $2,496 | $46 |
| Omeprazole | 215 | $2,096 | $10 |
| Carvedilol | 244 | $1,905 | $8 |
| Metoprolol | 246 | $1,827 | $7 |
| Atorvastatin | 145 | $1,780 | $12 |
| Omega-3 Acid Ethyl Esters | 24 | $1,498 | $62 |
| Hydralazine | 58 | $1,443 | $25 |
| Amlodipine Besylate | 193 | $1,388 | $7 |
| Losartan | 119 | $1,322 | $11 |
| Enalapril Maleate | 17 | $1,277 | $75 |
| Furosemide | 261 | $1,248 | $5 |
| Lisinopril | 218 | $1,156 | $5 |
| Potassium Citrate Er | 12 | $1,119 | $93 |
| Tamsulosin | 61 | $1,097 | $18 |
| Azathioprine | 15 | $1,000 | $67 |
| Doxazosin Mesylate | 30 | $906 | $30 |
| Ultra-Fine Mini Pen Needle | 13 | $862 | $66 |
| Allopurinol | 49 | $786 | $16 |
| Alendronate | 106 | $763 | $7 |
| Calcium Acetate | 14 | $659 | $47 |
| Nystatin | 26 | $552 | $21 |
| Sulfamethoxazole-Trimethoprim | 90 | $513 | $6 |
| Fludrocortisone Acetate | 13 | $419 | $32 |
| Simvastatin | 90 | $417 | $5 |
| Ranitidine | 33 | $401 | $12 |
| Gemfibrozil | 34 | $332 | $10 |
| Clonidine | 43 | $303 | $7 |
| Nifedical Xl | 17 | $295 | $17 |
| Acyclovir | 18 | $228 | $13 |
| Ciprofloxacin | 26 | $215 | $8 |
| Pravastatin | 12 | $183 | $15 |
| Torsemide | 11 | $148 | $13 |
| Spironolactone | 18 | $144 | $8 |
| Minoxidil | 25 | $119 | $5 |
| Lovastatin | 12 | $108 | $9 |
| Finasteride | 11 | $100 | $9 |
| Zolpidem | 19 | $89 | $5 |
| Gabapentin | 13 | $52 | $4 |
| Alprazolam | 11 | $18 | $2 |
2016: 49 drugs
| Valganciclovir | 47 | $106,015 | $2,256 |
| Mycophenolic Acid | 83 | $47,293 | $570 |
| Tacrolimus | 109 | $15,777 | $145 |
| Sensipar | 18 | $14,464 | $804 |
| Nexium | 18 | $7,775 | $432 |
| Vytorin | 19 | $7,743 | $408 |
| Crestor | 23 | $6,734 | $293 |
| Nifedipine Er | 202 | $6,732 | $33 |
| Cyclosporine Modified | 39 | $5,659 | $145 |
| Ursodiol | 22 | $5,119 | $233 |
| Prednisone | 724 | $5,018 | $7 |
| Leflunomide | 21 | $4,881 | $232 |
| Lantus Solostar | 21 | $4,483 | $213 |
| Mycophenolate Mofetil | 52 | $3,743 | $72 |
| Pantoprazole | 309 | $3,204 | $10 |
| Nifedical Xl | 154 | $3,198 | $21 |
| Metoprolol | 116 | $3,061 | $26 |
| Calcitriol | 133 | $2,973 | $22 |
| Omeprazole | 241 | $2,285 | $9 |
| Potassium Chloride | 49 | $2,221 | $45 |
| Atorvastatin | 151 | $2,030 | $13 |
| Labetalol | 45 | $1,998 | $44 |
| Metoprolol | 259 | $1,780 | $7 |
| Carvedilol | 223 | $1,732 | $8 |
| Alendronate | 162 | $1,459 | $9 |
| Hydralazine | 64 | $1,263 | $20 |
| Azathioprine | 21 | $1,249 | $59 |
| Furosemide | 278 | $1,227 | $4 |
| Omega-3 Acid Ethyl Esters | 14 | $1,183 | $85 |
| Amlodipine Besylate | 164 | $1,077 | $7 |
| Enalapril Maleate | 23 | $1,000 | $43 |
| Losartan | 111 | $990 | $9 |
| Lisinopril | 226 | $990 | $4 |
| Tamsulosin | 48 | $924 | $19 |
| Allopurinol | 50 | $754 | $15 |
| Doxazosin Mesylate | 31 | $700 | $23 |
| Sulfamethoxazole-Trimethoprim | 157 | $670 | $4 |
| Simvastatin | 101 | $616 | $6 |
| Pravastatin | 22 | $509 | $23 |
| Clonidine | 69 | $499 | $7 |
| Acyclovir | 21 | $445 | $21 |
| Nystatin | 15 | $385 | $26 |
| Ciprofloxacin | 26 | $285 | $11 |
| Gemfibrozil | 43 | $284 | $7 |
| Ranitidine | 28 | $211 | $8 |
| Minoxidil | 21 | $207 | $10 |
| Atenolol | 30 | $192 | $6 |
| Gabapentin | 20 | $123 | $6 |
| Spironolactone | 12 | $58 | $5 |
2015: 53 drugs
| Valganciclovir | 23 | $54,939 | $2,389 |
| Mycophenolic Acid | 43 | $26,208 | $609 |
| Myfortic | 17 | $18,488 | $1,088 |
| Tacrolimus | 58 | $11,902 | $205 |
| Sensipar | 11 | $10,434 | $949 |
| Crestor | 26 | $6,860 | $264 |
| Nexium | 14 | $6,822 | $487 |
| Vytorin | 25 | $6,818 | $273 |
| Nifedipine Er | 133 | $4,841 | $36 |
| Prednisone | 595 | $4,329 | $7 |
| Lantus Solostar | 17 | $3,685 | $217 |
| Ursodiol | 15 | $3,318 | $221 |
| Cyclosporine Modified | 34 | $3,084 | $91 |
| Pantoprazole | 215 | $2,224 | $10 |
| Metoprolol | 65 | $1,922 | $30 |
| Metoprolol | 267 | $1,602 | $6 |
| Calcitriol | 62 | $1,577 | $25 |
| Nifedical Xl | 87 | $1,554 | $18 |
| Atorvastatin | 120 | $1,450 | $12 |
| Potassium Chloride | 24 | $1,313 | $55 |
| Labetalol | 24 | $1,298 | $54 |
| Omega-3 Acid Ethyl Esters | 13 | $1,240 | $95 |
| Mycophenolate Mofetil | 25 | $1,236 | $49 |
| Enalapril Maleate | 37 | $1,201 | $32 |
| Omeprazole | 164 | $1,189 | $7 |
| Hydralazine | 54 | $970 | $18 |
| Bd Ultra-Fine Pen Needle | 23 | $924 | $40 |
| Losartan | 97 | $865 | $9 |
| Tamsulosin | 45 | $840 | $19 |
| Amlodipine Besylate | 150 | $820 | $5 |
| Furosemide | 173 | $744 | $4 |
| Allopurinol | 56 | $708 | $13 |
| Lisinopril | 144 | $637 | $4 |
| Azathioprine | 14 | $634 | $45 |
| Carvedilol | 91 | $633 | $7 |
| Doxazosin Mesylate | 20 | $598 | $30 |
| Clonidine | 91 | $598 | $7 |
| Minoxidil | 34 | $573 | $17 |
| Simvastatin | 118 | $459 | $4 |
| Pravastatin | 15 | $401 | $27 |
| Acyclovir | 20 | $396 | $20 |
| Alendronate | 48 | $318 | $7 |
| Levothyroxine | 22 | $308 | $14 |
| Atenolol | 59 | $305 | $5 |
| Sulfamethoxazole-Trimethoprim | 66 | $257 | $4 |
| Gabapentin | 29 | $204 | $7 |
| Gemfibrozil | 18 | $164 | $9 |
| Lovastatin | 12 | $145 | $12 |
| Ranitidine | 30 | $137 | $5 |
| Hydrochlorothiazide | 20 | $137 | $7 |
| Ciprofloxacin | 20 | $112 | $6 |
| Isosorbide Mononitrate Er | 13 | $112 | $9 |
| Tramadol | 14 | $84 | $6 |
2014: 57 drugs
| Mycophenolic Acid | 42 | $36,285 | $864 |
| Tacrolimus | 70 | $29,053 | $415 |
| Valcyte | 21 | $27,165 | $1,294 |
| Myfortic | 24 | $20,107 | $838 |
| Sensipar | 16 | $11,210 | $701 |
| Nexium | 21 | $10,130 | $482 |
| Prograf | 12 | $8,701 | $725 |
| Vytorin | 30 | $5,703 | $190 |
| Nifedipine Er | 114 | $5,098 | $45 |
| Humalog | 17 | $4,879 | $287 |
| Crestor | 18 | $3,792 | $211 |
| Prednisone | 454 | $3,604 | $8 |
| Labetalol | 37 | $2,852 | $77 |
| Lantus Solostar | 16 | $2,840 | $177 |
| Nifedical Xl | 95 | $2,601 | $27 |
| Metoprolol | 56 | $2,149 | $38 |
| Mycophenolate Mofetil | 26 | $2,007 | $77 |
| Ursodiol | 11 | $1,893 | $172 |
| Pantoprazole | 156 | $1,868 | $12 |
| Hydralazine | 61 | $1,755 | $29 |
| Metoprolol | 257 | $1,626 | $6 |
| Atorvastatin | 98 | $1,416 | $14 |
| Afeditab Cr | 25 | $1,369 | $55 |
| Omeprazole | 133 | $1,304 | $10 |
| Carvedilol | 62 | $1,159 | $19 |
| Calcitriol | 46 | $1,122 | $24 |
| Losartan | 106 | $1,043 | $10 |
| Temazepam | 11 | $983 | $89 |
| Bd Ultra-Fine Pen Needle | 17 | $971 | $57 |
| Amlodipine Besylate | 115 | $924 | $8 |
| Clotrimazole | 21 | $883 | $42 |
| Furosemide | 200 | $808 | $4 |
| Lisinopril | 134 | $782 | $6 |
| Acyclovir | 27 | $750 | $28 |
| Lansoprazole | 17 | $657 | $39 |
| Clonidine | 85 | $656 | $8 |
| Tamsulosin | 46 | $635 | $14 |
| Simvastatin | 90 | $605 | $7 |
| Enalapril Maleate | 45 | $581 | $13 |
| Doxazosin Mesylate | 17 | $577 | $34 |
| Potassium Chloride | 16 | $481 | $30 |
| Minoxidil | 17 | $434 | $26 |
| Gemfibrozil | 23 | $352 | $15 |
| Isosorbide Mononitrate Er | 28 | $344 | $12 |
| Atenolol | 55 | $325 | $6 |
| Azathioprine | 24 | $313 | $13 |
| Sulfamethoxazole-Trimethoprim | 44 | $270 | $6 |
| Alendronate | 34 | $255 | $8 |
| Allopurinol | 39 | $252 | $6 |
| Lovastatin | 18 | $223 | $12 |
| Levothyroxine | 15 | $208 | $14 |
| Glipizide Er | 16 | $190 | $12 |
| Metoclopramide | 16 | $170 | $11 |
| Ciprofloxacin | 19 | $118 | $6 |
| Ranitidine | 21 | $111 | $5 |
| Hydrochlorothiazide | 14 | $84 | $6 |
| Tramadol | 12 | $76 | $6 |
2013: 49 drugs
| Valcyte | 27 | $41,293 | $1,529 |
| Myfortic | 36 | $34,663 | $963 |
| Tacrolimus | 41 | $17,099 | $417 |
| Nexium | 23 | $9,147 | $398 |
| Prograf | 11 | $8,054 | $732 |
| Sensipar | 12 | $5,588 | $466 |
| Nifedipine Er | 82 | $4,038 | $49 |
| Edecrin | 13 | $3,485 | $268 |
| Vytorin | 17 | $2,812 | $165 |
| Labetalol | 33 | $2,668 | $81 |
| Metoprolol | 46 | $2,486 | $54 |
| Lantus Solostar | 11 | $2,236 | $203 |
| Nifedical Xl | 50 | $1,670 | $33 |
| Pantoprazole | 113 | $1,662 | $15 |
| Prednisone | 332 | $1,502 | $5 |
| Fenofibrate | 12 | $1,353 | $113 |
| Metoprolol | 199 | $1,339 | $7 |
| Hydralazine | 36 | $1,266 | $35 |
| Bd Ultra-Fine Pen Needle | 18 | $1,169 | $65 |
| Temazepam | 13 | $1,143 | $88 |
| Omeprazole | 102 | $1,131 | $11 |
| Potassium Chloride | 29 | $978 | $34 |
| Atorvastatin | 51 | $970 | $19 |
| Minoxidil | 31 | $960 | $31 |
| Losartan | 61 | $957 | $16 |
| Lisinopril | 145 | $854 | $6 |
| Afeditab Cr | 13 | $803 | $62 |
| Clonidine | 96 | $786 | $8 |
| Potassium Citrate | 11 | $754 | $69 |
| Amlodipine Besylate | 104 | $703 | $7 |
| Clotrimazole | 11 | $641 | $58 |
| Simvastatin | 70 | $584 | $8 |
| Calcitriol | 15 | $399 | $27 |
| Furosemide | 95 | $377 | $4 |
| Atenolol | 52 | $374 | $7 |
| Tamsulosin | 18 | $366 | $20 |
| Enalapril Maleate | 26 | $358 | $14 |
| Escitalopram | 13 | $339 | $26 |
| Alendronate | 36 | $331 | $9 |
| Acyclovir | 15 | $323 | $22 |
| Doxazosin Mesylate | 22 | $283 | $13 |
| Metoclopramide | 24 | $229 | $10 |
| Glipizide Er | 16 | $210 | $13 |
| Ciprofloxacin | 21 | $195 | $9 |
| Sulfamethoxazole-Trimethoprim | 29 | $189 | $7 |
| Lovastatin | 17 | $186 | $11 |
| Ranitidine | 23 | $132 | $6 |
| Hydrochlorothiazide | 12 | $106 | $9 |
| Carvedilol | 13 | $102 | $8 |
Professional record
- NPI
- 1750336459
- Licence
- CA A68748California A68748: Current · expires 2027-05-31
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-05-23
- NPI last updated
- 2024-04-19
- NPI record certified
- 2024-04-19
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.